OTC : NNCSF

Nanosonics Limited

$2.55 USD

$0 (0.0%)

Volume
100
Average Volume
204
Market Capitalization
$762.22M
P/E Ratio
45.05
Dividend Yield
0.00%
Price Target
Year High
$3.06
Year Low
$2.01
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$6.38
Company Overview

OTC

Michael C. Kavanagh

Medical - Instruments & Supplies

Healthcare

NNCSF

470

AU

USD

https://www.nanosonics.com.au

61 2 8063 1600

N/A

N/A

Liquidity Metrics

0.04

6.38

5.75

4.37

0.00

Sales & Valuation

$198.93M

4.40

4.22

37.39

0.08

Profitability

$0.0669

$20.68M

9.91%

10.61%

9.57%

7.36%

P/E Metrics

45.05

1.79

1.79

Analyst Price Target & Rating

Neutral

3/5

0 Analysts

%

Financial Health Scores

14.02

5/9

$196.66M

$279.14M

$59.54M

$40.62M

Key Metrics (TTM)

$773.69M

3.73

26.62

6.38

9.57%

7.04%

2.19%

2.64%

$1.05

160 days

Company Executives
Name Title
Ronan Wright Regional President of Europe, Middle East & Africa (EMEA)
Rod Lopez Chief Operating Officer
Derek Minihane BSEE Chief Technology Officer
Jason Burriss Chief Financial Officer
Jonathan Burdach Chief Medical Affairs & Scientific Officer
Matthew Carbines General Counsel & Company Secretary
Michael C. Kavanagh Chief Executive Officer, President, MD & Executive Director
Sunny Pillai Chief Information Officer
Catherine Strong Head of Investor Relations & Corporate Communications
Jodi Sampson Chief People & Culture Officer
Kimberly Hill Chief Marketing Officer & Regional President of Asia Pacific
Poll Results

No votes yet today — be the first to share your view!

About Nanosonics Limited (OTC:NNCSF) Stock

Nanosonics Limited, in conjunction with its subsidiaries, functions as an infection prevention enterprise, serving both Australian and international markets. The company's core activities involve the production and supply of the trophon ultrasound probe disinfector, alongside its complementary consumables and accessories. Furthermore, Nanosonics is committed to the research, development, and market introduction of innovative infection control and decontamination products and related technologies. Its product portfolio features the trophon2, a sophisticated device for high-level disinfection of ultrasound probes; trophon EPR, a specialized low-temperature, high-level disinfection solution specifically for intra-cavity ultrasound transducers; and Nanosonics AuditPro, a comprehensive system f ... or managing compliance with infection control workflows. Established in 2000, Nanosonics Limited maintains its corporate headquarters in Macquarie Park, Australia.

Frequently Asked Questions

What is the current Nanosonics Limited (NNCSF) stock price?

Nanosonics Limited(OTC:NNCSF) stock price is $2.55 in the last trading session. During the trading session, NNCSF stock reached the peak price of $3.0575 while $2.01 was the lowest point it dropped to. The percentage change in NNCSF stock occurred in the recent session was 0.0% while the dollar amount for the price change in NNCSF stock was $0.

NNCSF's industry and sector of operation?

The OTC listed NNCSF is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.

Who are the executives of NNCSF?

Ronan Wright | Regional President of Europe, Middle East & Africa (EMEA)
Rod Lopez | Chief Operating Officer
Derek Minihane BSEE | Chief Technology Officer
Jason Burriss | Chief Financial Officer
Jonathan Burdach | Chief Medical Affairs & Scientific Officer

How many employees does NNCSF have?

Number of NNCSF employees currently stands at 470. NNCSF operates from Building A, Macquarie Park, NSW 2113, AU.

Link for NNCSF official website?

Official Website of NNCSF is: https://www.nanosonics.com.au

How do I contact NNCSF?

NNCSF could be contacted at phone #61 2 8063 1600 and can also be accessed through its website. NNCSF operates from Building A, Macquarie Park, NSW 2113, AU.

How many shares of NNCSF are traded daily?

The average number of NNCSF shares traded daily for last 3 months was 204.

What is the market cap of NNCSF currently?

The market value of NNCSF currently stands at $762.22M with its latest stock price at $2.55